Actively Recruiting
Gastrointestinal Microflora and Serum Metabolomics in Patients With Pancreatic Cancer and Chronic Pancreatitis
Led by Changhai Hospital · Updated on 2024-05-13
600
Participants Needed
1
Research Sites
88 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators plan to collect throat swabs, saliva, feces and serum samples from pancreatic cancer patients, chronic pancreatitis patients and healthy people and clarify the characteristics of oral flora and serum metabolome of pancreatic cancer patients.
CONDITIONS
Official Title
Gastrointestinal Microflora and Serum Metabolomics in Patients With Pancreatic Cancer and Chronic Pancreatitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pathologic diagnosis of pancreatic ductal adenocarcinoma
- Diagnosis of chronic pancreatitis defined by obvious morphological features such as pancreatic calcifications on CT scan or magnetic resonance cholangiopancreatography
- Other benign disease populations without pancreatic lesions
You will not qualify if you...
- Pregnant women
- Patients with coagulation disorders unable to undergo blood tests
- History of using antibiotics or probiotics within the past 3 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Changhai Hospital
Shanghai, Shanghai Municipality, China, 200433
Actively Recruiting
Research Team
X
Xiangyu Kong, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here